LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Certified by Founder
Lodge
NewLimit
start up
United States
- South San Francisco, California
- 18/05/2023
- Series A
- $40,000,000
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
- Industry Biotechnology Research
- Website https://www.newlimit.com/
- LinkedIn https://www.linkedin.com/company/newlimit/people/
Related People
Blake ByersCo Founder
United States -
San Francisco Bay Area
I build and invest in tech and biotech companies. I try to maintain excess capacity so I have time for the weird, fringe ideas that are often the way we positively shape the future.
https://www.byerscap.com/
LinkedIn
https://www.linkedin.com/in/blbyers/
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)